<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78778E97-5A2E-40A6-A88F-137A343A3530"><gtr:id>78778E97-5A2E-40A6-A88F-137A343A3530</gtr:id><gtr:name>University of Toronto</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E30B7145-0051-47F4-B2D6-C93EE14B8568"><gtr:id>E30B7145-0051-47F4-B2D6-C93EE14B8568</gtr:id><gtr:name>University of Oslo</gtr:name><gtr:address><gtr:line1>Boks 1072 Blindern</gtr:line1><gtr:line4>Oslo</gtr:line4><gtr:line5>NO 0316</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Norway</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F0218A50-2D74-431E-9B66-7B583688A24A"><gtr:id>F0218A50-2D74-431E-9B66-7B583688A24A</gtr:id><gtr:name>Kumamoto University</gtr:name><gtr:address><gtr:line1>Kumamoto University</gtr:line1><gtr:line2>Honjo 1-1-1</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:department>Health and Population Sciences</gtr:department><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78778E97-5A2E-40A6-A88F-137A343A3530"><gtr:id>78778E97-5A2E-40A6-A88F-137A343A3530</gtr:id><gtr:name>University of Toronto</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E30B7145-0051-47F4-B2D6-C93EE14B8568"><gtr:id>E30B7145-0051-47F4-B2D6-C93EE14B8568</gtr:id><gtr:name>University of Oslo</gtr:name><gtr:address><gtr:line1>Boks 1072 Blindern</gtr:line1><gtr:line4>Oslo</gtr:line4><gtr:line5>NO 0316</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Norway</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F0218A50-2D74-431E-9B66-7B583688A24A"><gtr:id>F0218A50-2D74-431E-9B66-7B583688A24A</gtr:id><gtr:name>Kumamoto University</gtr:name><gtr:address><gtr:line1>Kumamoto University</gtr:line1><gtr:line2>Honjo 1-1-1</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/E8EE1BC9-799D-4921-8C12-8689B9552A74"><gtr:id>E8EE1BC9-799D-4921-8C12-8689B9552A74</gtr:id><gtr:firstName>Jon</gtr:firstName><gtr:surname>Frampton</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/1E2E96FA-1C32-4B2F-9B21-AB84D73DAF16"><gtr:id>1E2E96FA-1C32-4B2F-9B21-AB84D73DAF16</gtr:id><gtr:firstName>Laura</gtr:firstName><gtr:otherNames>Patricia</gtr:otherNames><gtr:surname>O'Neill</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0501688"><gtr:id>88F7EC89-9AFE-45C6-8A9B-4D18874AFD83</gtr:id><gtr:title>Defining the mechanism of c-Myb involvement in the regulation of haemopoietic stem cells</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0501688</gtr:grantReference><gtr:abstractText>Blood stem cells provide the constant supply of new blood cells throughout life, and they are also important in disease; for example, their ability to replace a patient?s own cells underpins bone marrow transplantation as a therapy for leukaemia and leukaemia-related diseases, whereas on the other hand, mutated versions of blood stem cells are thought to underlie many leukaemias. The unique properties of stem cells depend largely on their profile of active genes, which in turn is controlled by specialised proteins called transcription factors that act as molecular switches. One such protein that appears to be a key in the activation of genes in blood stem cells is c-Myb. This project aims to investigate how and to what extent c-Myb acts as a switch of gene activation in blood stem cells. The work will be performed using stem cells purified from the bone marrow of mice genetically modified to have altered amounts of c-Myb so as to induce changes in the balance of gene activities that it normally controls. The knowledge gained from this study will help to complete the picture of the network of molecular processes that are crucial for normal blood stem cell function, and will have wider implications for the understanding of stem cells in normal and disease situations and perhaps ultimately for their manipulation in a therapeutic context.</gtr:abstractText><gtr:technicalSummary>Haemopoietic stem cells (HSCs) reside in small numbers in the bone marrow where they serve as a continuous source of blood cells throughout life. The maintenance of HSCs and their ability to respond to the requirements for differentiated cells requires tight regulation of the balance between cell division (self-renewal) and commitment to differentiate. The regulation of gene expression is central to the behaviour of HSCs, and recently a number of transcriptional regulators have been demonstrated to play a role, although the details of the molecular mechanisms involved and the interplay between different regulators remains unclear. We have identified the c-Myb protein, which is known to be essential for haemopoietic development, as an essential regulator of HSC maintenance. In HSCs, c-Myb appears to influence expression of other transcription factors and signalling molecules that are themselves known to be important in stem cell function. The proposed project aims to investigate the link between c-Myb and the transcription factor Ikaros, and the role that both proteins play in controlling expression of the stem cell receptor tyrosine kinases c-Kit and Flt-3. Purified bone marrow HSCs will be derived from mice genetically modified to express lower levels of c-Myb or undergoing conditional ablation of the c-myb gene. c-Myb-dependent changes in Ikaros expression as well as the overall influence of c-Myb on gene regulation will be probed directly in purified HSCs by in situ immunofluorescence using antibodies against Ikaros or histone modifications characteristic of gene repression or activation. The part played by Ikaros in the overall effect of reduced c-Myb activity will be determined by infection of modified HSCs with Ikaros-expressing lentiviruses. To investigate the mechanism by which c-Myb affects Ikaros gene expression, we will use DNAse hypersensitivity and histone modifications as indicators of chromatin remodelling and transcriptional activity. The initial studies on the Ikaros gene will be performed in a model HSC line, but we will also apply a novel procedure for chromatin immunoprecipitation to investigate epigenetic marks of gene regulation in small numbers of purified HSCs, comparing the Ikaros gene locus in conditions of normal or reduced c-Myb expression.</gtr:technicalSummary><gtr:fund><gtr:end>2010-07-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-05-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>302553</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Toronto</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:department>McEwen Centre for Regenerative Medicine</gtr:department><gtr:description>Use of c-myb KD ES cells to study smooth muscle differentiation</gtr:description><gtr:id>40ADB817-4520-4A14-8753-AF0845634197</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>rrtDnLL5q2s-1</gtr:outcomeId><gtr:partnerContribution>Use of the c-myb KD ES cells to study commitment and differentiation processes</gtr:partnerContribution><gtr:piContribution>Provision of cells and know how regarding their culture etc</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oslo</gtr:collaboratingOrganisation><gtr:country>Norway, Kingdom of</gtr:country><gtr:description>Rescue of c-Myb deficiency through c-myb KO ES cells</gtr:description><gtr:id>AE15FE0E-520A-43C3-A951-CE2920ECF362</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>apM8A8sDeCc-1</gtr:outcomeId><gtr:partnerContribution>Genetic modification of ES cells and assessment of c-Myb function</gtr:partnerContribution><gtr:piContribution>Provision of ES cells and expertise</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Clinical Sciences Centre (CSC)</gtr:department><gtr:description>Provision of Ikaros reagents/know how</gtr:description><gtr:id>61E98DEF-C032-4F31-B65F-C7BABA8B1F8F</gtr:id><gtr:impact>It appears that ikaros can rescue many aspects of the c-myb knock down phenotype, confirming its pivotal role as a target of c-Myb</gtr:impact><gtr:outcomeId>221B1E1943C-1</gtr:outcomeId><gtr:partnerContribution>Provision of reagents/expertise in relation to the study of ikaros</gtr:partnerContribution><gtr:piContribution>We have investigated to what extent expression of ikaros, a c-Myb target gene, can explain the effects of c-Myb on haemopoietic stem cells</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Kumamoto</gtr:collaboratingOrganisation><gtr:country>Japan</gtr:country><gtr:description>The role of protein stability in the control of Myb levels in HSC</gtr:description><gtr:id>BE5FB5B6-8FEE-4BCA-97B9-5BBE02875677</gtr:id><gtr:impact>Publication in Stem Cells in 2014</gtr:impact><gtr:outcomeId>5463313e18f4d5.21368941-1</gtr:outcomeId><gtr:partnerContribution>Jointly developed and created mouse strain. Now working together on experiments using reporter mouse to monitor Myb levels in primary HSC</gtr:partnerContribution><gtr:piContribution>Initial concept and planning for development of new mouse strain, and hosting collaborator to initiate project</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School visit</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>8AA8D00D-1780-4B97-81DF-AE8E228D115C</gtr:id><gtr:impact>Mixed audience of pupils and parents in a secondary school

None yet apart from lively questioning</gtr:impact><gtr:outcomeId>hudFx9SZSgB</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Society of Biology Charter Lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>592B814A-7583-41DC-99AA-F30B3CD0780F</gtr:id><gtr:impact>Talk lead to extensive questioning and follow up questions by email

Outcomes awaited - only given recently</gtr:impact><gtr:outcomeId>54632c53565c83.68266201</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>830000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Leukaemia Research Specialist Programme Grant</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>Leukaemia and Lymphoma Research</gtr:fundingOrg><gtr:id>FCE8AC40-474E-4F46-A93F-0239AC37A5D4</gtr:id><gtr:outcomeId>8BB3C603FD20</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1396658</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Mechanisms central to the development and maintenance of myeloid disease: The role of Myb family proteins and their potential for therapeutic intervention</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>Leukaemia and Lymphoma Research</gtr:fundingOrg><gtr:id>57BD8F2E-F6C8-41C2-9AB1-D36EE0C448E5</gtr:id><gtr:outcomeId>cuA8MiV7iYE</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>ES cells homozygous for the myb kd allele constitutively expressing ikaros 2 isoform</gtr:description><gtr:id>AC0B1E3D-2B93-4A06-81EB-01F32F58A365</gtr:id><gtr:impact>Chimeras generated from this line have demonstrated that ikaros can rescue many of the stem cell defects caused by decreased c-myb expression</gtr:impact><gtr:outcomeId>8CEBA796234</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>ES myb kd/ikaros</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>myb knockdown ES cells</gtr:description><gtr:id>44E58CFE-4A40-4BD4-9C94-B6EC4C7E1BEA</gtr:id><gtr:impact>Has enabled generation of chimeras to assess the cell autonomous effects of reduced c-myb expression</gtr:impact><gtr:outcomeId>EE10F6FCFCC</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>ES myb kd</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>F0C0F154-C394-4B6E-AF10-D44BA60F942B</gtr:id><gtr:title>Regulation of the Flt3 Gene in Haematopoietic Stem and Early Progenitor Cells.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e2cebd9c1c2830d681ef2ace611d4831"><gtr:id>e2cebd9c1c2830d681ef2ace611d4831</gtr:id><gtr:otherNames>Volpe G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56dee025ea8d54.61886407</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C9A1B1A1-B2C6-4B5D-B187-0C0F0D5CB8FB</gtr:id><gtr:title>Reduced c-Myb activity compromises HSCs and leads to a myeloproliferation with a novel stem cell basis.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa18b698d6c171aeaa610cd1ccdea763"><gtr:id>aa18b698d6c171aeaa610cd1ccdea763</gtr:id><gtr:otherNames>Garc?a P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>N6DEDMNUCVb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>784617EF-1D20-43DD-B28F-3A7AAD3383C7</gtr:id><gtr:title>C/EBPa and MYB regulate FLT3 expression in AML.</gtr:title><gtr:parentPublicationTitle>Leukemia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e2cebd9c1c2830d681ef2ace611d4831"><gtr:id>e2cebd9c1c2830d681ef2ace611d4831</gtr:id><gtr:otherNames>Volpe G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0887-6924</gtr:issn><gtr:outcomeId>58b84a10872cb3.24074793</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0211632E-248A-4D98-9A2A-AFC91A32EFCC</gtr:id><gtr:title>Critical roles for c-Myb in lymphoid priming and early B-cell development.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/49c00a159e3d19b6bdc18f49ec16fbad"><gtr:id>49c00a159e3d19b6bdc18f49ec16fbad</gtr:id><gtr:otherNames>Greig KT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>djEf1u9cZsj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5EDD39B8-4202-48F1-85C7-3370F9CF6C24</gtr:id><gtr:title>c-Myb and GATA-1 alternate dominant roles during megakaryocyte differentiation.</gtr:title><gtr:parentPublicationTitle>Journal of thrombosis and haemostasis : JTH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa18b698d6c171aeaa610cd1ccdea763"><gtr:id>aa18b698d6c171aeaa610cd1ccdea763</gtr:id><gtr:otherNames>Garc?a P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1538-7836</gtr:issn><gtr:outcomeId>rBoY2RkH4rN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7536707E-635C-485A-B3A6-61B57D1E3199</gtr:id><gtr:title>Transcriptional regulation of SPROUTY2 by MYB influences myeloid cell proliferation and stem cell properties by enhancing responsiveness to IL-3.</gtr:title><gtr:parentPublicationTitle>Leukemia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f10f6b8faa715faa1a1670e0712441c4"><gtr:id>f10f6b8faa715faa1a1670e0712441c4</gtr:id><gtr:otherNames>Clarke M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0887-6924</gtr:issn><gtr:outcomeId>58b84a10617fe1.48645074</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>309376D1-7C41-4485-B2C9-6D49CCCAB551</gtr:id><gtr:title>Determining c-Myb protein levels can isolate functional hematopoietic stem cell subtypes.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/06c945536ca15b161e63087b1a915680"><gtr:id>06c945536ca15b161e63087b1a915680</gtr:id><gtr:otherNames>Sakamoto H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>54624affbc8df6.92607398</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0501688</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>939798CA-B6AE-4C12-9DCC-A0F88F84E6F3</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Blood</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>